home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Enzyme Implicated in Restless Legs Syndrome

 
  August, 7 2008 17:19
your information resource in human molecular genetics
 
     
A new genetic variant has been implicated in risk of restless legs syndrome, according to a study published online in Nature Genetics.

Restless legs syndrome is a neurological disorder characterized by pain in the lower limbs and the frequent urge to move, which leads to sleep disturbance. Juliane Winkelmann and colleagues show that a variant in the gene PTPRD is associated with increased risk of the disorder in several populations of affected individuals. PTPRD encodes one of a family of enzymes called protein tyrosine phosphatases, and this particular phosphatase has been shown in mice to function in the development of neurons that directly or indirectly control movement.

Author contact:

Juliane Winkelmann (Max Plancke Institute of Human Genetics, Munich, Germany)
E-mail: winkelmann@lrz.tu-muenchen.de

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.